Evidence map›Paper›PMID 41965847›Full record

ArticleBlood cancer journal2026

Impact of SARS-CoV-2 vaccination on monoclonal gammopathy of undetermined significance: results from the population-based iStopMM study.

Robert Palmason, Elias Eythorsson, Sæmundur Rögnvaldsson, Sigrún Thorsteinsdóttir, Sara Ekberg, Michael Crowther, Elin Ruth Reed, Jon Þórir Oskarsson, Gudrun Asta Sigurdardottir, Thor Aspelund and 22 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Blood cancer journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

32 authors.

Robert PalmasonLandspitali University Hospital, Reykjavik, Iceland.
Elias EythorssonLandspitali University Hospital, Reykjavik, Iceland.
Sæmundur RögnvaldssonLandspitali University Hospital, Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-2162-8414
Sigrún ThorsteinsdóttirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-5017-3530
Sara EkbergRed Door Analytics AB, Stockholm, Sweden.
Michael CrowtherRed Door Analytics AB, Stockholm, Sweden.
Elin Ruth ReedFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Jon Þórir OskarssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-9201-1166
Gudrun Asta SigurdardottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Thor AspelundFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0002-7998-5433
Brynjar VidarssonLandspitali University Hospital, Reykjavik, Iceland.
Pall Torfi OnundarsonLandspitali University Hospital, Reykjavik, Iceland.
Bjarni Agnar AgnarssonLandspitali University Hospital, Reykjavik, Iceland.
Margret SigurdardottirLandspitali University Hospital, Reykjavik, Iceland.
Ingunn ThorsteinsdottirLandspitali University Hospital, Reykjavik, Iceland.
Signy Vala SveinsdottirLandspitali University Hospital, Reykjavik, Iceland.
Isleifur OlafssonLandspitali University Hospital, Reykjavik, Iceland.
Asdis Rosa ThordardottirFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Asbjorn JonssonAkureyri Hospital, Akureyri, Iceland.
Olafur S IndridasonLandspitali University Hospital, Reykjavik, Iceland.
Gauti GislasonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.ORCID http://orcid.org/0000-0003-4710-0781
Andri OlafssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Jon Kristinn SigurdssonFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Hlif SteingrimsdottirLandspitali University Hospital, Reykjavik, Iceland.
Thorir Einarsson LongSkane University Hospital, Lund, Sweden.
Malin HultcrantzMyeloma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.ORCID http://orcid.org/0000-0002-9045-6495
Brian G M DurieSamuel Oschin Comprehensive Cancer Institute, Cedars-Sinai Outpatient Cancer Center, Los Angeles, CA, USA.
Stephen HardingThe Binding Site, part of Thermo Fisher Scientific, Birmingham, United Kingdom.
Ola LandgrenMyeloma Program, Department of Medicine, University of Miami, Sylvester Comprehensive Cancer Center, Miami, FL, USA.ORCID http://orcid.org/0000-0001-6485-4839
Runolfur PalssonLandspitali University Hospital, Reykjavik, Iceland.ORCID http://orcid.org/0000-0001-6763-1702
Thorvardur Jon LoveFaculty of Medicine, University of Iceland, Reykjavik, Iceland.
Sigurdur Yngvi KristinssonLandspitali University Hospital, Reykjavik, Iceland. Sigyngvi@hi.is.ORCID http://orcid.org/0000-0002-4964-7476

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
NCI NIH HHS P30 CA008748
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID41965847
PMCPMC13181031

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.